tiprankstipranks
Trending News
More News >
Sihuan Pharmaceutical Holdings Group Ltd. (HK:0460)
:0460
Hong Kong Market

Sihuan Pharmaceutical Holdings Group (0460) Financial Statements

Compare
1 Followers

Sihuan Pharmaceutical Holdings Group Financial Overview

Sihuan Pharmaceutical Holdings Group's market cap is currently $10.92B. The company's EPS TTM is HK$-0.025; its P/E ratio is ―; and it has a dividend yield of 1.79%. Sihuan Pharmaceutical Holdings Group is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.90B¥ 1.86B¥ 2.18B¥ 3.04B¥ 2.46B
Gross Profit¥ 1.24B¥ 1.30B¥ 1.49B¥ 2.43B¥ 1.91B
Operating Income¥ -138.13M¥ 161.70M¥ -536.03M¥ 676.20M¥ 485.82M
EBITDA¥ -208.66M¥ 334.31M¥ -1.54B¥ 931.69M¥ 714.06M
Net Income¥ -216.66M¥ -54.02M¥ -1.95B¥ 416.51M¥ 473.38M
Balance Sheet
Cash & Short-Term Investments¥ 3.63B¥ 4.37B¥ 4.79B¥ 5.79B¥ 4.94B
Total Assets¥ 10.53B¥ 11.54B¥ 12.14B¥ 14.50B¥ 13.04B
Total Debt¥ 942.76M¥ 1.26B¥ 1.19B¥ 1.08B¥ 755.05M
Net Debt¥ -2.58B¥ -2.63B¥ -2.63B¥ -4.60B¥ -3.85B
Total Liabilities¥ 5.58B¥ 6.40B¥ 6.50B¥ 5.35B¥ 3.10B
Stockholders' Equity¥ 4.37B¥ 4.43B¥ 4.74B¥ 8.28B¥ 9.19B
Cash Flow
Free Cash Flow¥ 0.00¥ -95.93M¥ -355.97M¥ 64.28M¥ -279.51M
Operating Cash Flow¥ 0.00¥ 199.49M¥ 46.49M¥ 665.29M¥ 227.13M
Investing Cash Flow¥ 0.00¥ 169.88M¥ -1.66B¥ -337.57M¥ -924.78M
Financing Cash Flow¥ 0.00¥ -419.56M¥ -238.93M¥ 750.66M¥ 184.54M
Currency in CNY

Sihuan Pharmaceutical Holdings Group Earnings and Revenue History

Sihuan Pharmaceutical Holdings Group Debt to Assets

Sihuan Pharmaceutical Holdings Group Cash Flow

Sihuan Pharmaceutical Holdings Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis